Back to MW MARSHALL WACE, LLP

ALLOALLO
19 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ALLOGENE THERAPEUTICS INC

Yes. Marshall Wace holds 5,095,408 shares of ALLO (Allogene Therapeutics), worth $10.6M, as of its Q2 2026 13F filing. It increased the position by 1,647,424 shares (+47.8%) from Q1 2026. Marshall Wace has held ALLO since Q4 2025, across 3 quarterly 13F filings.

Current Value

$10.6M

Current Shares

5.1M

Total Value Change

+$8.8M

Total Shares Change

+5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.1M
+47.8%
$10.6M0.0%$2.08
38
2026-Q1
Increased
3.4M
+1107.4%
$8.4M0.0%$2.44
44
2025-Q4
New
285,561
-
$391,2180.0%$1.37
33
2023-Q4
Exited
0
-100.0%
$00.0%$3.21
0
2023-Q3
Increased
228,642
+427.5%
$724,7960.0%$3.17
40
2023-Q2
Decreased
43,346
-90.0%
$215,4310.0%$4.97
0
2023-Q1
New
435,020
-
$2.1M0.0%$4.94
36
2022-Q4
Exited
0
-100.0%
$00.0%$6.29
0
2022-Q3
New
12,593
-
$136,0000.0%$10.80
31
2022-Q1
Exited
0
-100.0%
$00.0%$9.11
0
2021-Q4
New
948,624
-
$14.2M0.0%$14.92
39
2021-Q3
Exited
0
-100.0%
$00.0%$25.70
0
2021-Q2
New
456,591
-
$11.9M0.1%$26.08
39
2020-Q2
Exited
0
-100.0%
$00.0%$42.82
0
2020-Q1
Decreased
132,006
-13.8%
$2.6M0.0%$19.44
0
2019-Q4
New
153,105
-
$4M0.0%$25.98
37
2019-Q3
Exited
0
-100.0%
$00.0%$27.26
0
2019-Q2
Decreased
19,524
-68.3%
$525,0000.0%$26.85
0
2019-Q1
New
61,642
-
$1.8M0.0%$28.91
36

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used